Cambridge, Massachusetts
United States
39
2014-04-03
35
2013-10-22
These are the the leading inventors for applications assigned to Immunogen, Inc.:
Immunogen, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Anti-Integrin Immunoconjugates, Methods and Uses
#2 | 2010-06-03METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
#3 | 2008-07-17 ✅ Patent 8,563,509 granted on 2013-10-22Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
#4 | 2008-07-17 ✅ Patent 7,989,598 granted on 2011-08-02Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
#5 | 2008-06-19 ✅ Patent 8,198,417 granted on 2012-06-12Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
#6 | 2008-06-12METHODS FOR IMPROVING ANTIBODY PRODUCTION
#7 | 2008-05-20 ✅ Patent 7,374,762 granted on 2008-05-20Drug conjugate composition
#8 | 2008-05-15 ✅ Patent 8,163,888 granted on 2012-04-24Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
#9 | 2008-05-06 ✅ Patent 7,368,565 granted on 2008-05-06Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
#10 | 2008-02-12 ✅ Patent 7,329,760 granted on 2008-02-12CC-1065 analog synthesis
#11 | 2007-12-04 ✅ Patent 7,303,749 granted on 2007-12-04Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
#12 | 2007-11-22 ✅ Patent 7,473,796 granted on 2009-01-06Cytotoxic agents comprising new maytansinoids
#13 | 2007-11-22 ✅ Patent 8,435,528 granted on 2013-05-07Cytotoxic agents comprising new maytansinoids
#14 | 2007-11-15 ✅ Patent 7,851,432 granted on 2010-12-14Cytotoxic agents comprising new maytansinoids
#15 | 2007-08-09 ✅ Patent 8,840,898 granted on 2014-09-23Immunoconjugates targeting syndecan-1 expressing cells and use thereof
#16 | 2007-04-12 ✅ Patent 7,358,088 granted on 2008-04-15Peptides and compositions which modulate apoptosis
#17 | 2007-04-10 ✅ Patent 7,202,346 granted on 2007-04-10Antibodies to non-shed Muc1 and Muc16, and uses thereof
#18 | 2007-04-10 ✅ Patent 7,202,024 granted on 2007-04-10bbc3 Gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
#19 | 2007-03-20 ✅ Patent 7,193,044 granted on 2007-03-20Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
#20 | 2007-03-01 ✅ Patent 7,811,572 granted on 2010-10-12Process for preparing purified drug conjugates
#21 | 2007-01-11 ✅ Patent 7,501,120 granted on 2009-03-10Drug conjugate composition
#22 | 2007-01-11 ✅ Patent 7,494,649 granted on 2009-02-24Drug conjugate composition
#23 | 2007-01-11 ✅ Patent 7,514,080 granted on 2009-04-07Drug conjugate composition
#24 | 2006-08-29 ✅ Patent 7,097,982 granted on 2006-08-29Peptides and compositions which modulate apoptosis
#25 | 2006-08-29 ✅ Patent 7,097,840 granted on 2006-08-29Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
#26 | 2006-08-17Process for preparing stable drug conjugates
#27 | 2006-08-10 ✅ Patent 7,342,110 granted on 2008-03-11Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
#28 | 2006-07-27 ✅ Patent 7,301,019 granted on 2007-11-27Method for the preparation of maytansinoid esters
#29 | 2006-07-18 ✅ Patent 7,078,175 granted on 2006-07-18Antibodies for apoptosis EI24 protein and methods of use
#30 | 2006-06-15 ✅ Patent 8,603,483 granted on 2013-12-10Anti-integrin immunoconjugates, methods and uses
#31 | 2006-05-23 ✅ Patent 7,049,316 granted on 2006-05-23Prodrugs of CC-1065 analogs
#32 | 2006-05-18 ✅ Patent 7,276,499 granted on 2007-10-02Cytotoxic agents comprising taxanes and their therapeutic use
#33 | 2006-03-07 ✅ Patent 7,008,942 granted on 2006-03-07Cytotoxic agents comprising taxanes and their therapeutic use
#34 | 2005-12-08 ✅ Patent 7,217,819 granted on 2007-05-15Cytotoxic agents comprising taxanes and their therapeutic use
#35 | 2005-11-17 ✅ Patent 7,186,851 granted on 2007-03-06Facile method for synthesizing baccatin III compounds
#36 | 2005-07-05 ✅ Patent 6,913,748 granted on 2005-07-05Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
#37 | 2005-04-21 ✅ Patent 7,414,073 granted on 2008-08-19Cytotoxic agents containing novel potent taxanes and their therapeutic use
#38 | 2005-02-03 ✅ Patent 7,495,114 granted on 2009-02-24Cytotoxic agents containing novel potent taxanes and their therapeutic use
#39 | 2005-01-06 ✅ Patent 7,192,750 granted on 2007-03-20Mutant strain with increased maytansinoid production
60315 ⎘